07/07/2026
Our Recovery Story: Complete Resolution of Documented Conditions
Updated July 2026
All previously documented medical conditions have been fully resolved. We have taken no pharmaceutical medications and have not required ongoing medical care (except for verification of our recovery) since 2019/2020.
We believe individuals should have access to information and personal experiences so they can conduct their own research and make informed decisions in consultation with their healthcare providers.
We are not doctors and do not provide medical advice. We do not claim that Amanita muscaria, cannabis, Lion’s Mane, psilocybin, or any other substance cured or treated any disease. We are simply sharing one family’s fully documented recovery journey.
🌿 Recovery Protocol
Our approach combined several natural substances over multiple years as part of a comprehensive lifestyle and wellness program:
* Amanita muscaria (dried caps and tinctures)
* Medical cannabis (including a pasteurization method that produces no psychoactive effects)
* Activated cannabis preparations
* Rick Simpson Oil (RSO)
* Lion’s Mane mushroom
* Psilocybin mushrooms
📋 Resolved Conditions
The following conditions were formally documented in physician records and are now considered fully resolved:
1. Alzheimer’s Disease (diagnosed 2017) RESOLVED
2. Mild Cognitive Impairment RESOLVED
3. Coronary Artery Disease (post-CABG 2010) RESOLVED
4. Neuropathy RESOLVED
5. Lumbar Radiculopathy RESOLVED
6. Generalized Anxiety Disorder RESOLVED
7. Insomnia RESOLVED
8. Hypertension RESOLVED
9. Hyperlipidemia RESOLVED
10. Depression RESOLVED
11. History of Substance Abuse RESOLVED
12. Left Humerus Fracture (surgically repaired) RESOLVED
📄 Medical Record Timeline
2017
* Received initial Alzheimer’s Disease diagnosis.
* Began exploring alternative wellness approaches.
2017–2018
* Discontinued all prescription medications.
* Transitioned fully to plant- and mushroom-based protocols.
2019
* Neurology evaluation noted Mild Cognitive Impairment.
* Physician documented: “The patient currently has no neurological issues.”
* Began actively seeking formal validation of recovery.
October 29, 2020
* Primary Care visit: PHQ-9 Depression Score = 0.
* No prescription medications listed.
* Physician noted the patient was “doing well.”
* Alzheimer’s Disease officially documented as RESOLVED.
2020–Present
* No pharmaceutical drugs taken.
* No routine medical care except for recovery documentation.
* Cognitive function has remained stable or improved for approximately 7–8 years since the original diagnosis.
* All listed conditions remain resolved.
💊 Current Status (2026)
* Zero prescription medications
* Zero pharmaceutical drugs
* Using only plant- and mushroom-based protocols
* No ongoing medical supervision beyond recovery verification
🧠 Key Lessons
1. The human body possesses remarkable healing capacity when properly supported.
2. Thorough medical documentation is essential for validating recovery.
3. Plant and mushroom medicines may serve as valuable tools in wellness journeys.
4. Lifestyle factors play a critical role in long-term health.
5. Recovery from “incurable” conditions can be documented through standard medical records.
⚠️ Important Disclaimer
Individual results vary significantly. Personal recovery stories are not scientific evidence of effectiveness for any condition.
We strongly encourage everyone to:
* Review the scientific literature
* Examine primary medical records
* Consult qualified healthcare professionals
* Make informed decisions based on evidence and professional guidance
Our purpose is to share information transparently, promote education, and encourage open, honest discussion about wellness and recovery.
Share Our Storyhttps://www.facebook.com/share/p/1EWL26ueXn/?mibextid=wwXIfr
Note on Censorship: We have experienced repeated interference with our websites and social media accounts, including altered posts and content removal. If links become inaccessible after refreshing, please document it.
___________
A BILL TO BE ENTITLED (Post are being altered by Malicious actors, we are currently updating names of those involved, including officials, agencies, and others that have been contacted for transparency, truth will not be silenced. We have hard copies)
AN ACT to amend Tennessee Code Annotated, Title 39 and Title 68, relating to limited patient protections for hemp-derived cannabinoid preparations.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the “Tennessee Patient Access and Education Act.”
SECTION 2. PURPOSE AND LEGISLATIVE FINDINGS. The General Assembly finds that:
Certain debilitating or life-threatening medical conditions may warrant consideration of emerging therapeutic research involving cannabinoid compounds.
Some hemp-derived cannabinoid preparations are designed to minimize psychoactive impairment and may present distinct public policy considerations from intoxicating or recreational use.
Patients and healthcare providers benefit from accurate, evidence-based medical information regarding safe preparation methods and risk awareness.
It is the policy of this state to distinguish clearly between intoxicating use and narrowly tailored medical access protections.
The General Assembly recognizes the Medical Cannabis Commission’s ongoing study of federal and state laws regarding medical cannabis and the development of legislation to establish an effective, patient-focused medical cannabis program in this state, pending federal rescheduling or descheduling of ma*****na from Schedule I of the Controlled Substances Act.
The purpose of this Act is to establish limited legal protections for qualified patients using hemp-derived cannabinoid preparations with proper medical documentation, to safeguard the exchange of medically accurate educational information, and to promote evidence-based stewardship of therapeutic options while ensuring public safety and compliance with applicable laws.
SECTION 3. DEFINITIONS.
As used in this Act:
“Debilitating medical condition” refers to a chronic or life-threatening disease or condition, including but not limited to:
Cancer, particularly in end-stage or associated wasting illness, recalcitrant nausea, vomiting, or pain;
Epilepsy or seizures;
Alzheimer’s disease;
Amyotrophic lateral sclerosis (ALS);
Multiple sclerosis;
Crohn’s disease and ulcerative colitis;
Post-traumatic stress disorder (PTSD);
HIV/AIDS;
Parkinson’s disease;
Sickle cell disease;
Quadriplegia;
Intractable pain;
Persistent muscle spasms; or
Any other condition certified by a licensed healthcare provider as similarly debilitating.
“Hemp-derived cannabinoid preparation” means a formulation derived from the cannabis plant or its derivatives, containing no more than 0.9% THC by dry weight, in accordance with Tennessee Code Annotated § 39-17-402. These preparations must be non-combustible and administered via topical, transdermal, sublingual, oral tincture, edible, or other non-smoking/non-vaporizing methods. This definition excludes smoking, vaporization, and combustible forms. It does not authorize products prohibited by law, including those banned under Public Chapter 526 (HB 1376).
“Qualified patient” means a Tennessee resident diagnosed with a debilitating medical condition by a licensed healthcare provider and possessing valid medical documentation.
“Medical documentation” is a written statement signed by a licensed Tennessee healthcare provider, on a prescribed form, stating that the patient has a debilitating condition and may benefit from hemp-derived cannabinoid preparations. The documentation includes the diagnosis, recommended preparation type or category, and an expiration date not exceeding 12 months.
“Healthcare provider” refers to a licensed medical doctor or doctor of osteopathic medicine practicing in Tennessee.
“Registered caregiver” means a person at least 21 years old, designated by a qualified patient (or legal guardian), to assist with obtaining or administering preparations, and registered with the Department of Health.
SECTION 4. LIMITED POSSESSION DEFENSE.A qualified patient or registered caregiver shall have an affirmative defense against prosecution under Tennessee law (including Title 39, Chapter 17, Part 4) for possession, acquisition, or use of hemp-derived cannabinoid preparations, provided:
The quantity does not exceed a 30-day personal supply, not to exceed 2 ounces (56.7 grams), or as defined by rules of the Department of Health.
The preparation is non-combustible and complies with the definition in Section 3.
This defense applies only if the individual possesses the required medical documentation at the time of the alleged offense.
This section does not authorize:
Public consumption, smoking, or vaporization of cannabinoid preparations;
Operation of motor vehicles or heavy machinery while impaired;
Possession or use on school grounds, childcare facilities, or correctional institutions;
Employer requirements for workplace accommodations;
Home cultivation; or
Any conflict with or preemption of federal law.
SECTION 5. EDUCATION AND INFORMATION PROTECTIONS. No healthcare provider, caregiver, nonprofit organization, or individual shall face criminal, civil, or professional penalties solely for providing medically accurate, evidence-based information regarding hemp-derived cannabinoid preparations.
Activities protected include discussing:
Safe, non-combustible methods of preparation and administration;
Risk awareness, dosage, and impairment considerations;
Peer-reviewed research on cannabinoid science and therapeutic uses.
This section does not authorize unlicensed distribution, sale, or recreational promotion.
SECTION 6. RULEMAKING AUTHORITY. The Department of Health, in consultation with the Tennessee Medical Board where appropriate, shall promulgate rules under the Administrative Procedures Act to implement this Act. Rules shall include, but are not limited to:
Medical documentation forms;
Possession and supply limits;
Registry procedures for patients and caregivers;
Safety, labeling, and testing requirements;
Healthcare provider education;
Adverse event reporting; and
Verification procedures for law enforcement.
Initial rules shall be adopted within 12 months of the Act’s effective date.
SECTION 7. SEVERABILITY. If any provision of this Act or its application to any person or circumstance is held invalid, such invalidity shall not affect other provisions or applications that can be given effect without the invalid provision.
SECTION 8. REPORTING REQUIREMENT. The Department of Health shall submit a report to the General Assembly by January 1, 2029, and annually thereafter, evaluating utilization, public safety impacts, healthcare outcomes, and recommending adjustments as needed.
SECTION 9. EFFECTIVE DATE. This Act shall become law upon approval, with the public welfare requiring it.